-
401
-
402
Tolerability and Effectiveness of Regorafenib Treatment in Patients with Unresectable Hepatocellular Carcinoma: Real-World Data from the United States
Published 2025-02-01“…Richard S Finn,1 Renuka Iyer,2 Richard S Kalman,3 Neehar D Parikh,4 Roniel Cabrera,5 Svetlana Babajanyan,6 Ahmed O Kaseb7 1Department of Medicine, University of California, Los Angeles, CA, USA; 2Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, USA; 3Department of Medicine, Einstein Medical Center, Philadelphia, PA, USA; 4Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI, USA; 5Department of Medicine, University of Florida Health, Gainesville, FL, USA; 6US Medical Affairs, Oncology, Bayer Healthcare, Whippany, NJ, USA; 7Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USACorrespondence: Richard S Finn, Department of Medicine, University of California, Los Angeles, CA, USA, Tel +1-310-586-2091, Email rfinn@mednet.ucla.eduIntroduction: While several systemic therapies are available for unresectable hepatocellular carcinoma (uHCC), there is a lack of granular real-world evidence to support the efficacy and safety of these therapies. …”
Get full text
Article -
403
-
404
Parry–Romberg Syndrome with Uhthoff’s Phenomena: A Spectrum of Autoimmune Disease?
Published 2019-01-01Get full text
Article -
405
-
406
-
407
Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy
Published 2025-01-01Get full text
Article -
408
-
409
Comparative evaluation of an AI-powered life coach against traditional coaching methods
Published 2025-02-01Get full text
Article -
410
Low Thermal Resistance of Diamond‐AlGaN Interfaces Achieved Using Carbide Interlayers
Published 2025-02-01Get full text
Article -
411
-
412
-
413
-
414
-
415
-
416
-
417
Qualitative Behaviour of Solutions in Two Models of Thin Liquid Films
Published 2016-01-01Get full text
Article -
418
Variables que diferencian a estudiantes de bachillerato con y sin aptitudes intelectuales sobresalientes
Published 2013-12-01Get full text
Article -
419
-
420
Ipilimumab: A First-in-Class T-Cell Potentiator for Metastatic Melanoma
Published 2013-01-01Get full text
Article